Trial studying safety and effects for Menorrhagia
Official title to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
ClinicalTrials.gov ID: NCT07378098
What this study is testing
- What it's testing
- The study wants to find out if KLH-2109 lowers or reduces menstrual bleeding and if it is safe to use.
- Who it's for
- Women who have uterine fibroids and experience heavy menstrual bleeding.
- What's involved
- Participants will take either KLH-2109 or a standard treatment pill, visit the clinic regularly for check‑ups and safety tests, and record their bleeding and any health changes.
- Time commitment
- The study lasts several months and requires regular clinic visits for monitoring and testing.
- Phase 3: a large, late-stage study
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older, women only
You may be able to join if
- Individuals diagnosed with uterine fibroids
You likely can't join if
- Metrorrhagia or anovulatory bleeding
- Patients with a history of total hysterectomy or bilateral oophorectomy
The study team makes the final eligibility decision.
Where it is enrolling
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Seoul, South Korea. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.